Parallel Advisors, LLC

Position in MLYS — Mineralys Therapeutics, Inc.

CIK 1690010 SAN FRANCISCO, CA

Position in MLYS

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$593

-$2 QoQ

Shares Held

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#214

of 224 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Parallel Advisors, LLC holds $359,916,636 across 168 Biotechnology names. MLYS ranks #142 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CORT	Corcept Therapeutics Inc	3,962,177	$344,511,290
2	VRTX	Vertex Pharmaceuticals Inc / Ma	5,389	$2,676,877
3	RCUS	Arcus Biosciences, Inc.	86,557	$2,668,552
4	REGN	Regeneron Pharmaceuticals, Inc.	1,063	$662,823
5	KRYS	Krystal Biotech, Inc.	1,699	$631,467
6	ARGX	Argenx SE	640	$593,772
7	INCY	Incyte Corp	4,961	$562,378
8	VKTX	Viking Therapeutics, Inc.	13,833	$539,625

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$593	22	0.0%	Shares	Sole	2026-08-05
2026-03-31	$595	22	0.0%	Shares	Sole	2026-05-07
2025-12-31	$798	22	0.0%	Shares	Sole	2026-02-11
2025-09-30	$834	22	0.0%	Shares	Sole	2025-11-13
2025-06-30	$297	22	0.0%	Shares	Sole	2025-07-08
2025-03-31	$349	22	0.0%	Shares	Sole	2025-04-08
2024-12-31	$270	22	0.0%	Shares	Sole	2025-02-10
2024-09-30	$266	22	0.0%	Shares	Sole	2024-11-13
2024-06-30	$257	22	0.0%	Shares	Sole	2024-08-08
2024-03-31	$284	22	-86.2%	Shares	Sole	2024-05-06
2023-12-31	$1,367	159	—	Shares	Sole	2024-02-12
No filing history on record for this holder in this stock.